Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 172

1.

A Susceptible Mouse Model for Zika Virus Infection.

Dowall SD, Graham VA, Rayner E, Atkinson B, Hall G, Watson RJ, Bosworth A, Bonney LC, Kitchen S, Hewson R.

PLoS Negl Trop Dis. 2016 May 5;10(5):e0004658. doi: 10.1371/journal.pntd.0004658. eCollection 2016 May.

2.

The predictive power of airborne gamma ray survey data on the locations of domestic radon hazards in Norway: A strong case for utilizing airborne data in large-scale radon potential mapping.

Smethurst MA, Watson RJ, Baranwal VC, Rudjord AL, Finne I.

J Environ Radioact. 2016 Apr 19. pii: S0265-931X(16)30096-0. doi: 10.1016/j.jenvrad.2016.04.006. [Epub ahead of print]

3.

A flow cytometry method for rapidly assessing M. tuberculosis responses to antibiotics with different modes of action.

Hendon-Dunn CL, Doris KS, Thomas SR, Allnutt JC, Marriott AA, Hatch KA, Watson RJ, Bottley G, Marsh PD, Taylor SC, Bacon J.

Antimicrob Agents Chemother. 2016 Feb 22. pii: AAC.02712-15. [Epub ahead of print]

4.

HPV 16E7 and 48E7 proteins use different mechanisms to target p130 to overcome cell cycle block.

Nor Rashid N, Yong ZL, Yusof R, Watson RJ.

Virol J. 2016 Jan 4;13:2. doi: 10.1186/s12985-015-0460-8.

5.

Navigating CYP1A Induction and Arylhydrocarbon Receptor Agonism in Drug Discovery. A Case History with S1P1 Agonists.

Taylor SJ, Demont EH, Gray J, Deeks N, Patel A, Nguyen D, Taylor M, Hood S, Watson RJ, Bit RA, McClure F, Ashall H, Witherington J.

J Med Chem. 2015 Oct 22;58(20):8236-56. doi: 10.1021/acs.jmedchem.5b01102. Epub 2015 Oct 1.

PMID:
26393276
6.

Structure-Based Optimization of Naphthyridones into Potent ATAD2 Bromodomain Inhibitors.

Bamborough P, Chung CW, Furze RC, Grandi P, Michon AM, Sheppard RJ, Barnett H, Diallo H, Dixon DP, Douault C, Jones EJ, Karamshi B, Mitchell DJ, Prinjha RK, Rau C, Watson RJ, Werner T, Demont EH.

J Med Chem. 2015 Aug 13;58(15):6151-78. doi: 10.1021/acs.jmedchem.5b00773. Epub 2015 Jul 31.

PMID:
26230603
7.

Fragment-Based Discovery of Low-Micromolar ATAD2 Bromodomain Inhibitors.

Demont EH, Chung CW, Furze RC, Grandi P, Michon AM, Wellaway C, Barrett N, Bridges AM, Craggs PD, Diallo H, Dixon DP, Douault C, Emmons AJ, Jones EJ, Karamshi BV, Locke K, Mitchell DJ, Mouzon BH, Prinjha RK, Roberts AD, Sheppard RJ, Watson RJ, Bamborough P.

J Med Chem. 2015 Jul 23;58(14):5649-73. doi: 10.1021/acs.jmedchem.5b00772. Epub 2015 Jul 9.

PMID:
26155854
8.

1,3-Dimethyl Benzimidazolones Are Potent, Selective Inhibitors of the BRPF1 Bromodomain.

Demont EH, Bamborough P, Chung CW, Craggs PD, Fallon D, Gordon LJ, Grandi P, Hobbs CI, Hussain J, Jones EJ, Le Gall A, Michon AM, Mitchell DJ, Prinjha RK, Roberts AD, Sheppard RJ, Watson RJ.

ACS Med Chem Lett. 2014 Sep 10;5(11):1190-5. doi: 10.1021/ml5002932. eCollection 2014 Nov 13.

9.

Real-time microfluidic recombinase polymerase amplification for the toxin B gene of Clostridium difficile on a SlipChip platform.

Tsaloglou MN, Watson RJ, Rushworth CM, Zhao Y, Niu X, Sutton JM, Morgan H.

Analyst. 2015 Jan 7;140(1):258-64. doi: 10.1039/c4an01683a.

PMID:
25371968
10.

A B-myb--DREAM complex is not critical to regulate the G2/M genes in HPV-transformed cell lines.

Rashid NN, Yusof R, Watson RJ.

Anticancer Res. 2014 Nov;34(11):6557-63.

PMID:
25368258
11.
12.

An ICP-MS procedure to determine Cd, Co, Cu, Ni, Pb and Zn in oceanic waters using in-line flow-injection with solid-phase extraction for preconcentration.

O'Sullivan JE, Watson RJ, Butler EC.

Talanta. 2013 Oct 15;115:999-1010. doi: 10.1016/j.talanta.2013.06.054. Epub 2013 Jul 16.

PMID:
24054694
13.

A method for making directed changes to the Fusarium graminearum genome without leaving markers or other extraneous DNA.

Watson RJ, Wang S.

Fungal Genet Biol. 2012 Jul;49(7):556-66. doi: 10.1016/j.fgb.2012.05.008. Epub 2012 Jun 1.

PMID:
22664277
14.

Binding of FoxM1 to G2/M gene promoters is dependent upon B-Myb.

Down CF, Millour J, Lam EW, Watson RJ.

Biochim Biophys Acta. 2012 Aug;1819(8):855-62. doi: 10.1016/j.bbagrm.2012.03.008. Epub 2012 Mar 30.

PMID:
22513242
15.

Discovery of GSK143, a highly potent, selective and orally efficacious spleen tyrosine kinase inhibitor.

Liddle J, Atkinson FL, Barker MD, Carter PS, Curtis NR, Davis RP, Douault C, Dickson MC, Elwes D, Garton NS, Gray M, Hayhow TG, Hobbs CI, Jones E, Leach S, Leavens K, Lewis HD, McCleary S, Neu M, Patel VK, Preston AG, Ramirez-Molina C, Shipley TJ, Skone PA, Smithers N, Somers DO, Walker AL, Watson RJ, Weingarten GG.

Bioorg Med Chem Lett. 2011 Oct 15;21(20):6188-94. doi: 10.1016/j.bmcl.2011.07.082. Epub 2011 Aug 12.

PMID:
21903390
16.

Disruption of repressive p130-DREAM complexes by human papillomavirus 16 E6/E7 oncoproteins is required for cell-cycle progression in cervical cancer cells.

Nor Rashid N, Yusof R, Watson RJ.

J Gen Virol. 2011 Nov;92(Pt 11):2620-7. doi: 10.1099/vir.0.035352-0. Epub 2011 Aug 3.

PMID:
21813705
17.

The role of iron uptake in pathogenicity and symbiosis in Photorhabdus luminescens TT01.

Watson RJ, Millichap P, Joyce SA, Reynolds S, Clarke DJ.

BMC Microbiol. 2010 Jun 22;10:177. doi: 10.1186/1471-2180-10-177.

18.

A Lin-9 complex is recruited by B-Myb to activate transcription of G2/M genes in undifferentiated embryonal carcinoma cells.

Knight AS, Notaridou M, Watson RJ.

Oncogene. 2009 Apr 16;28(15):1737-47. doi: 10.1038/onc.2009.22. Epub 2009 Mar 2.

PMID:
19252525
19.

A model for integration of DNA into the genome during transformation of Fusarium graminearum.

Watson RJ, Burchat S, Bosley J.

Fungal Genet Biol. 2008 Oct;45(10):1348-63. doi: 10.1016/j.fgb.2008.07.015. Epub 2008 Jul 31.

PMID:
18722542
20.

Development of CXCR3 antagonists. Part 4: discovery of 2-amino-(4-tropinyl)quinolines.

Knight RL, Allen DR, Birch HL, Chapman GA, Galvin FC, Jopling LA, Lock CJ, Meissner JW, Owen DA, Raphy G, Watson RJ, Williams SC.

Bioorg Med Chem Lett. 2008 Jan 15;18(2):629-33. Epub 2007 Nov 28.

PMID:
18068363
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk